Skip to main content

Intellectus Partners, LLC

SEC CIK
0001677253
Latest filing
Aug 12, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Intellectus Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
2,696
Value
$1.68M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of REGN by Intellectus Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,696$1.68M0.3%−19−0.7%ReducedHolders
Q1 20262,715$2.10M0.4%00.0%UnchangedHolders
Q4 20252,715$2.10M0.4%−28−1.0%ReducedHolders
Q3 20252,743$1.54M0.3%+93+3.5%AddedHolders
Q2 20252,650$1.39M0.3%+617+30.3%AddedHolders
Q1 20252,033$1.29M0.3%+978+92.7%AddedHolders
Q4 20241,055$751.5K0.2%00.0%UnchangedHolders
Q3 20241,055$1.11M0.3%00.0%UnchangedHolders
Q2 20241,055$1.11M0.3%−100−8.7%ReducedHolders
Q1 20241,155$1.11M0.3%−125−9.8%ReducedHolders
Q4 20231,280$1.12M0.3%00.0%UnchangedHolders
Q3 20231,280$1.05M0.3%−397−23.7%ReducedHolders
Q2 20231,677$1.20M0.4%−200−10.7%ReducedHolders
Q1 20231,877$1.54M0.5%+22+1.2%AddedHolders
Q4 20221,855$1.34M0.5%−42−2.2%ReducedHolders
Q3 20221,897$1.31M0.5%−88−4.4%ReducedHolders
Q2 20221,985$1.17M0.4%00.0%UnchangedHolders
Q1 20221,985$1.39M0.4%−175−8.1%ReducedHolders
Q4 20212,160$1.36M0.3%−550−20.3%ReducedHolders
Q3 20212,710$1.64M0.4%+215+8.6%AddedHolders
Q2 20212,495$1.39M0.3%+30+1.2%AddedHolders
Q1 20212,465$1.17M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.